Global Genomics Service
We Sequence, You Discover

THE NIFTY™ TEST

The World’s Leading Non-Invasive Prenatal Test (NIPT). Over 3 MILLION Samples Processed To Date.

THE NIFTY™ TEST

The World’s Leading Non-Invasive Prenatal Test (NIPT). Over 3 MILLION Samples Processed To Date.

SERVICES

Group 242

ONCOLOGY

BGI’s hereditary risk screening cancer panels target genes previously linked to a predisposition of cancer. Panel selection was based on expert curation of scientific literature and other high quality resources, including formal medical guidelines.

Group 243

REPRODUCTIVE HEALTH

VISTA™ Carrier Screening detects 15,000 mutations across 547 genes, for 626 autosomal-recessive and X-linked genetic disorders.
VISTA™ PGS is used in conjunction with an IVF cycle. Embryos remain on-site at the patient’s IVF center. Cells are removed from an embryo and sent to BGI for genetic analysis.

Group 245

NEWBORN SCREENING

Each year, an estimated 7.9 million babies worldwide are born with birth defects, Detecting a disease at an early stage can enable appropriate and timely medical intervention before more serious and sometimes irreversible health issues are caused.

Group 244

CLINICAL EXOME SEQUENCING

BGI’s Whole Clinical Exome Sequencing examines the DNA sequence of over 180,000 exons across 22,000 genes, screening for more than 4000 monogenic diseases.

BGI LOCAL LABORATORY SOLUTION

BGI is changing diagnostics by providing fast, affordable and comprehensive genetic knowledge.

Genetic disease raises many questions. We’re empowering healthcare providers with the information
they need to answer these questions, in order to both prevent disease and better guide patient treatment
decisions.

BGI acts as one of the world’s most tried and trusted clinical genomic partners with experience

in diagnostic and screening tests. We have a worldwide network of offices and laboratories.

BGI LOCAL LABORATORY SOLUTION

BGI is changing diagnostics by providing fast, affordable and comprehensive genetic knowledge.

Genetic disease raises many questions. We’re empowering healthcare providers with the information they need to answer these questions, in order to both prevent disease and better guide patient treatment decisions.

BGI acts as one of the world’s most tried and trusted clinical genomic partners with experience in diagnostic and screening tests. We have a worldwide network of offices and laboratories.